Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 156

    1.

    Adenovirus early region 3(E3) immunomodulatory genes decrease the incidence of autoimmune diabetes in NOD mice.

    Efrat S, Serreze D, Svetlanov A, Post CM, Johnson EA, Herold K, Horwitz M.

    Diabetes. 2001 May;50(5):980-4.PMID: 11334441 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Adenovirus early region 3 antiapoptotic 10.4K, 14.5K, and 14.7K genes decrease the incidence of autoimmune diabetes in NOD mice.

    Pierce MA, Chapman HD, Post CM, Svetlanov A, Efrat S, Horwitz M, Serreze DV.

    Diabetes. 2003 May;52(5):1119-27.PMID: 12716741 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.

    Grewal IS, Grewal KD, Wong FS, Picarella DE, Janeway CA Jr, Flavell RA.

    J Exp Med. 1996 Nov 1;184(5):1963-74.PMID: 8920883 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice.

    Wong FS, Visintin I, Wen L, Granata J, Flavell R, Janeway CA.

    J Exp Med. 1998 Jun 15;187(12):1985-93.PMID: 9625758 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.

    Silva DG, Petrovsky N, Socha L, Slattery R, Gatenby P, Charlton B.

    J Immunol. 2003 May 15;170(10):4996-5002.PMID: 12734343 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Expression of adenoviral E3 transgenes in beta cells prevents autoimmune diabetes.

    von Herrath MG, Efrat S, Oldstone MB, Horwitz MS.

    Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9808-13.PMID: 9275207 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.

    Chong MM, Chen Y, Darwiche R, Dudek NL, Irawaty W, Santamaria P, Allison J, Kay TW, Thomas HE.

    J Immunol. 2004 May 1;172(9):5714-21.PMID: 15100317 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    IFN beta accelerates autoimmune type 1 diabetes in nonobese diabetic mice and breaks the tolerance to beta cells in nondiabetes-prone mice.

    Alba A, Puertas MC, Carrillo J, Planas R, Ampudia R, Pastor X, Bosch F, Pujol-Borrell R, Verdaguer J, Vives-Pi M.

    J Immunol. 2004 Dec 1;173(11):6667-75.PMID: 15557158 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice.

    Kay TW, Parker JL, Stephens LA, Thomas HE, Allison J.

    J Immunol. 1996 Oct 15;157(8):3688-93.PMID: 8871671 [PubMed - indexed for MEDLINE]Related articles

    10.

    Beta-cell apoptosis in an accelerated model of autoimmune diabetes.

    Augstein P, Stephens LA, Allison J, Elefanty AG, Ekberg M, Kay TW, Harrison LC.

    Mol Med. 1998 Aug;4(8):495-501.PMID: 9742505 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants.

    Mathews CE, Graser RT, Savinov A, Serreze DV, Leiter EH.

    Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):235-40.PMID: 11136257 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.

    Moritani M, Yoshimoto K, Wong SF, Tanaka C, Yamaoka T, Sano T, Komagata Y, Miyazaki J, Kikutani H, Itakura M.

    J Clin Invest. 1998 Aug 1;102(3):499-506.PMID: 9691086 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Significant role for Fas in the pathogenesis of autoimmune diabetes.

    Su X, Hu Q, Kristan JM, Costa C, Shen Y, Gero D, Matis LA, Wang Y.

    J Immunol. 2000 Mar 1;164(5):2523-32.PMID: 10679090 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.

    Balasa B, La Cava A, Van Gunst K, Mocnik L, Balakrishna D, Nguyen N, Tucker L, Sarvetnick N.

    J Immunol. 2000 Dec 15;165(12):7330-7.PMID: 11120869 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.
    17.

    Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.

    Yoon JW, Jun HS.

    Ann N Y Acad Sci. 2001 Apr;928:200-11. Review.PMID: 11795511 [PubMed - indexed for MEDLINE]Related articles

    19.

    IFN-gamma affects homing of diabetogenic T cells.

    Savinov AY, Wong FS, Chervonsky AV.

    J Immunol. 2001 Dec 1;167(11):6637-43.PMID: 11714835 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.

    Balasa B, Van Gunst K, Jung N, Balakrishna D, Santamaria P, Hanafusa T, Itoh N, Sarvetnick N.

    J Immunol. 2000 Sep 1;165(5):2841-9.PMID: 10946317 [PubMed - indexed for MEDLINE]Related articlesFree article